TW200804429A - Process for the preparation of sugar-chain compound - Google Patents

Process for the preparation of sugar-chain compound Download PDF

Info

Publication number
TW200804429A
TW200804429A TW096110943A TW96110943A TW200804429A TW 200804429 A TW200804429 A TW 200804429A TW 096110943 A TW096110943 A TW 096110943A TW 96110943 A TW96110943 A TW 96110943A TW 200804429 A TW200804429 A TW 200804429A
Authority
TW
Taiwan
Prior art keywords
compound
group
formula
residue
sugar chain
Prior art date
Application number
TW096110943A
Other languages
Chinese (zh)
Inventor
Yasuhiro Kajihara
Yuri Nambu
Kazuhiro Fukae
Hiroaki Asai
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of TW200804429A publication Critical patent/TW200804429A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

This invention provides a process for the preparation of sugar-chain compound represented by formula (2), characterized by reacting a sugar-chain asparagine compound represented by formula (1) with a hydrazine hydrate. [wherein, R1, R2 and R3 are the same or different, each independently representing hydrogen or sugar residue, R4 represents hydrogen or fucose residue, Ac represents acetyl group, R5 represents hydrogen, fat-soluble protecting group, amino acid residue or peptide residue, R6 represents carboxyl group or-COOR7, R7 represents amino acid residue or peptide residue] [wherein, R1, R2, R3, R4 and Ac are the same meaning as above mentioned.]

Description

200804429 九、發明說明: -【發明所屬之技術領域】 • 本發明係關於切斷糖鏈天冬醯胺化合物之、矛厝“ 法。 原末&具有游離經基的糖鏈化合物之製造方 【先前技術】 糖鏈與蛋白質共價結合之 質中的榼4丄 于%為糖蛋白質。糖蛋白 •附力』: 維持蛋白質3次元構造或調節溶解性、 •附加蛋白酶耐性等作用。近來 生 鏈參與受精或分化、信號傳、隶、] 蛋白質中的糖 -或生理活性的調節等生命現象。為此,心 糖鏈於各種生理機能擔任重要角色。、二於蛋白貝之 的構造為多樣,其種類眾夕〜 …、由於該等糖鏈 參與生命現象為非常固難:狀:特:指出何種構造的糖鏈 具單-構造糖鏈之糖蛋二二等機能的解明, 者。 貝糖胜肽的合成為必要不可缺 根據糖與蛋白質結合樣 為2群。一群為天冬酿胺同’糖蛋白質可大致分 冬醒胺結合型糖鏈(N•結)側鍵的胺基與糖鏈結合之天 丁胺酸™的經基與_=另一群為絲胺酸(㈣絲 鏈(0結合型)。 …3之‘蛋白(mucin)結合型糖 本發明者們組合酵素法與化學法 製2分歧複合型糖鏈的方法 由硪蛋大里凋 末端具有游離經基之複 利^獻!),揭示由糖鏈還原 I搪鏈製造胺基化複合型糖鏈衍 3】9076 200804429 生物,並可將所製得之該衍生物選擇性的導入至胜肽的硫 醇基(專利文獻2)。 方、凋衣糖鏈還原末端具有游離羥基之N_結合型糖鏈 時,有由糖鏈天冬醯胺及其衍生物或糖蛋白質,藉由酵素 切出糖鏈的方法或化學性切斷的方法。—般化學性切斷方 去可使用則hydrazine)分解》。於肼水合物或水的存在下 使用肼時,由於糖鏈還原末端的糖脫離(沒脫離),故使用 無水肼。 [專利文獻l]WO 03/008431號公報 [專利文獻2]WO 2004/011036號公報 、然而,無水肼由於其毒性或發火性等,操作需要慎重, 為不適合大量處理的試劑,因而希望有安全有效之結合 型糖鏈切出方法。 本發明之目的,係提供與無水肼相比,安全地使用肼 水合物,製造於還原末端具有游離羥基之結合型糖鏈化 合物的方法。 【發明内容】 本發明係如下述之發明。 一 一種式(2)所示糖鏈化合物之製造方法,包括將式〇) 所不之糖鏈天冬醯胺化合物與肼水合物作用。200804429 IX. Description of the invention: - [Technical field to which the invention pertains] The present invention relates to a method for cutting a sugar chain aspartate compound, a spear "method. a raw sugar & a sugar chain compound having a free radical. [Prior Art] The sugar chain and the protein are covalently bonded to each other. The glycoprotein is attached to the protein. The glycoprotein is attached to the protein. The protein is maintained in a three-dimensional structure or the solubility is adjusted, and the protease resistance is added. The chain participates in life phenomena such as fertilization or differentiation of proteins in the fertilization or differentiation, signal transmission, and regulation of proteins. For this reason, the glycoside chain plays an important role in various physiological functions. , the type of the evening ~ ..., because the sugar chain is involved in the phenomenon of life is very difficult: Shape: Special: pointed out that the structure of the sugar chain with a single-structured sugar chain of sugar and egg two functions, such as. The synthesis of the shellose peptide is indispensable according to the combination of sugar and protein. The group of amines is the amine of the aspartame and the glycoprotein can be roughly divided into the side chain of the ammonia-binding sugar chain (N• knot). The base group of the tyrosine acid TM combined with the sugar chain and the other group are the serine acid ((4) silk chain (0 binding type). ... 3 'mucin binding type sugar. The inventors combined enzymes The method of chemical and chemical methods for the divergence of complex glycochains is based on the compound of the free radicals in the end of the quail eggs. It reveals that the amino chain-reduced I-chains from the sugar chains are used to make the aminated complexes. 3906074044 The thiol group of the peptide can be selectively introduced into the peptide (Patent Document 2). When the N-binding sugar chain having a free hydroxyl group at the reducing end of the sugar-coated chain is present, From the sugar chain aspartame and its derivatives or glycoproteins, the method of cutting sugar chains by enzymes or the method of chemical cutting. Generally, the chemical cutting can be used to break down the hydrazine. When hydrazine is used in the presence of hydrate or water, anhydrous sugar is used because the sugar at the end of the sugar chain is detached (no detachment). [Patent Document 1] WO 03/008431 [Patent Document 2] WO 2004/011036 Bulletin, however, anhydrous hydrazine requires operation due to its toxicity or flammability. It is a reagent which is not suitable for large-scale treatment, and therefore it is desirable to have a safe and effective method for binding sugar chain cutting. The object of the present invention is to provide safe use of hydrazine hydrate as compared with anhydrous hydrazine, and to have a free hydroxyl group at the reducing end. The present invention relates to the following invention. A method for producing a sugar chain compound represented by the formula (2), which comprises a sugar chain aspartame of the formula The amine compound acts with the hydrazine hydrate.

[式中’ 、R2及R3為相同或不同,表示氮原子或糖 319076 6 200804429 殘辱:R4表示氫原子或岩藻糖殘基;Ac表示乙醯基;R 二氫原子恥冷性保護基、胺基酸殘基或胜肽殘基;R 表讀基或;R7表示胺基酸殘基或胜肽殘基] (2) NHAc NHAc [式中R、R、及R4及Ac為與上述者相同]。 、、本1x月者們發現,使用目前為止由於產生冷脫離而無 会使用之肼水合物,進行肼分解,接著以苯甲基胺化合物 :代,精製後,經由水解處理,可製造於還原末端具有游 每麵基之N-結合型糖鏈化合物。 本發明之式(1)所示糖鏈天冬醯胺化合物,包含糖鏈與 天;I胺結合之糖蛋白質、糖胜肽或糖鏈天冬醯胺及盆等 之衍生物等。 /、 ★"本叙明之式(2)所示糖鏈化合物,係於還原末端具有游 離麵基之N-結合型糖鏈化合物。[wherein, R2 and R3 are the same or different and represent a nitrogen atom or a sugar 319076 6 200804429 Insult: R4 represents a hydrogen atom or a fucose residue; Ac represents an ethyl hydrazide group; and a dihydrogen atom of a dihydrogen atom , amino acid residue or peptide residue; R represents a reading group; R7 represents an amino acid residue or a peptide residue] (2) NHAc NHAc [wherein R, R, and R4 and Ac are as described above The same]. In the first month, it was found that the hydrazine hydrate which has not been used so far due to the occurrence of cold detachment is decomposed by hydrazine, and then purified by benzylamine compound, and then purified by hydrolysis. The end has an N-binding type sugar chain compound which slides on each surface. The oligosaccharide aspartame compound represented by the formula (1) of the present invention contains a sugar chain and a day; an amine-bound glycoprotein, a glycopeptide, a sugar chain aspartate, a derivative such as a pot, and the like. /, ★" The sugar chain compound represented by the formula (2) of the present invention is an N-binding type sugar chain compound having a free surface group at the reducing end.

[式t V為相同或不同’表示氫原子或糖 殘基;R4表示氫原子或岩藻糖殘基;Ac表示乙醯基;R5 表示氫原子、脂溶性保護基、胺基酸殘基或胜肽殘基;R6 表讀基S-COR7 ; V表示胺基酸殘基或胜肤殘基] 319076 7 200804429 R1 R4 NHAc NHAc (2) [式中,R1、R2、R3及R4及Ac為與上述者相同]。 糖殘基可為羥基經保護,亦可經氟等鹵原子取代之甘 露糖、N-乙醯基葡糖胺、半乳糖、岩藻糖等單糖,亦可為 該等單糖2者以上以糖苷結令形成糖鏈者。又,可為經氟 等鹵素取代之糖鏈,亦可為含有羧基經保護之唾液酸之糖 鍵。 亦即,式(1)所示糖鏈天冬醯胺化合物可為以往習知或 未知之糖鏈天冬醯胺、高甘露糖型糖鏈天冬醯胺化合物、 複合型糖鏈天冬醯胺化合物、混成型糖鏈天冬醯胺化合 物。式(2)所示糖鏈化合物亦可為以往習知或未知之糖鏈化 合物、高甘露糖型糖鏈化合物、複合型糖鏈化合物、混成 型糖鏈化合物。 脂溶性保護基並無特別限制,可列舉例如9-苐基曱氧 基幾基(Fmoc)或第三丁基氧基羰基(Boc)、稀丙基氧基獄基 (Alloc)等含有羰基之基,乙醯基(Ac)等醯基,烯丙基,苯 曱基等保護基等。該等保護基之導入,可根據例如[Formula t V is the same or different ' represents a hydrogen atom or a sugar residue; R4 represents a hydrogen atom or a fucose residue; Ac represents an ethyl hydrazide group; and R5 represents a hydrogen atom, a fat-soluble protecting group, an amino acid residue or Peptide residue; R6 is a reading group S-COR7; V represents an amino acid residue or a peptide residue] 319076 7 200804429 R1 R4 NHAc NHAc (2) [wherein R1, R2, R3 and R4 and Ac are Same as above]. The sugar residue may be a monosaccharide such as mannose, N-ethyl glucosamine, galactose or fucose which may be protected by a hydroxyl group or a halogen atom such as fluorine, or may be more than 2 of these monosaccharides. A glycoside is formed by a glycoside. Further, it may be a sugar chain substituted with a halogen such as fluorine, or a sugar chain containing a protected sialic acid of a carboxyl group. That is, the sugar chain aspartame compound represented by the formula (1) may be a conventionally known or unknown sugar chain aspartate, a high mannose type sugar chain aspartate compound, a complex sugar chain aspartate. An amine compound, a mixed sugar chain aspartate compound. The sugar chain compound represented by the formula (2) may be a conventionally known or unknown sugar chain compound, a high mannose type sugar chain compound, a complex type sugar chain compound, or a mixed type sugar chain compound. The fat-soluble protective group is not particularly limited, and examples thereof include a carbonyl group such as a 9-fluorenyloxyl group (Fmoc) or a tert-butyloxycarbonyl group (Boc) or a propyloxy group (Alloc). A protecting group such as a fluorenyl group such as an acetamino group (Ac), an allyl group or a benzoinyl group. The introduction of such protecting groups can be based on, for example

Protecting groups in Organic chemistry (John Wiley & Sons INC·,New York 1991,ISBN 0-471-62301-6)等習知方法進 行。 R5之胺基酸殘基或胜肽殘基為天冬醯胺之胺基與羧 基為醯胺結合之胺基酸或胜肽,並無特別限制。 8 319076 200804429 R7之胺基酸殘基或胜肽殘基為天冬酿胺之幾基鱼胺 -基為賴結合之胺基酸或胜肽,並無特別限制。 . 本方法所使用之肼水合物可使用以往習知者,可直接 使用肼-水合物,亦可以水稀釋使用,骄妾 可為重量%,特佳可為40至1〇〇重量;辰度 肼水合物之使用量,雖無特別限制,相對 ::::醯:化合物1當量宜為°.8當量以上,較二二 Γ里、由於一般事先使用溶媒因而可大量過剩使用, •目對於式(1)所示糖鏈天冬醯胺化合物 _重量份,較佳為100至5_重量份里知且為1至 本方法之反應可於加熱下、回流溫度下 咸信為式⑴所轉鏈天㈣胺化合物料u = 所示肼基化合物。根據本發明者們的研究,雖尚益 但發現歧離反應係於式⑴所示 化^ 生大部二或全部轉換為式(3)所示肼基糖二 全部轉二‘&⑴天冬酿胺化合物之大部分或 反應。()所不拼基糖鏈化合物為止,不發生万脫離 物全雖Γ進f至式⑴所示糖鍵天冬酿胺化合 或者因/3㈣Η作佳為接近完全消耗時即終止反應。 生之前成式(4)所示肼基糖鏈化合物的發 Ρ、、、;止反應為佳。及雁查六/土 亡一 質譜法進行追蹤。反應的終藉:::層析(TLC)或 J褚®中止加熱回流而進行。 3】9076 9 200804429Protecting groups in Organic Chemistry (John Wiley & Sons INC., New York 1991, ISBN 0-471-62301-6) and the like are carried out. The amino acid residue or the peptide residue of R5 is an amino acid of aspartame and an amino acid or a peptide having a carboxyl group which is a guanamine, and is not particularly limited. 8 319076 200804429 The amino acid residue or the peptide residue of R7 is an amino acid of the aspartame-based amino acid or a peptide, and is not particularly limited. The hydrazine hydrate used in the method can be used in the prior art, and can be directly used as a hydrazine-hydrate or a water-diluted solution, and the arrogant can be weight%, particularly preferably 40 to 1 〇〇 weight; The amount of the hydrazine hydrate to be used is not particularly limited, and the relative::::醯: the compound 1 equivalent is preferably 0.88 equivalent or more, which is more than a large amount of excess due to the use of a solvent in advance. The sugar chain aspartame compound represented by the formula (1) is preferably 100 to 5 parts by weight and is 1 to the reaction of the method, which can be heated under the reflux temperature and the formula (1) The chain of the amine (4) amine compound material u = the thiol compound shown. According to the study by the present inventors, it has been found that the dissociation reaction is based on the conversion of most of the two or all of the conversions shown in the formula (1) to the conversion of the thiol sugars represented by the formula (3) to the second '&(1) days. Most of the winter amine compounds or reactions. () The saccharide chain compound does not occur, and the detachment does not occur. However, the glycosylation of the sugar bond as shown in the formula (1) or the (3) oxime is preferably close to complete consumption. The reaction of the thiol chain compound represented by the formula (4) before birth is preferred. And Yancha six / soil death one mass spectrometry tracking. The final reaction of the reaction:: chromatography (TLC) or J褚® is stopped by heating and refluxing. 3] 9076 9 200804429

RxRx

NHNH2 (3) [式中,^以…及…為與上述者相同]。 R\NHNH2 (3) [wherein, ^ is ... and ... is the same as above]. R\

nhnh2 (4) [式中’ R、R2及R3為與上述者相同]。 本方法之反應中’式⑴所示之糖鏈天冬醯胺化合物 中由於具有乙酿基等酿胺結合型保護基,由於過剩的耕 而該等保護基脫離絲胺基。m乙si基化劑作用為 N-乙酸基化所必要。 … .乙^基化劑可使用於N_乙酸基化反應中所使用之以 彺白知之乙醯基化劑,例如,可例示如乙醯氯、乙醯溴等 乙醢齒化物或乙酸酐,較佳可使用乙酸肝。乙醯基化劑之 使用量,相對於胺基i當量為m當量,較佳^ 10當量左右。 · 使用乙醯基化劑之N_乙醯基化反應,可適用以往習知 的方法’例如於將上述反應液於減壓下餾除過剩的骈後, 於鹼存在下,以乙醯基化劑作用而完成。 驗’可使用以往習知者’例如可列舉碳酸納、碳酸 碳酸氫納等驗金屬石炭酸鹽,三乙胺、吼。定等有機驗等,特 佳為碳酸氫m定。驗的使用量雖無特別限制,相對於 乙酿基化劑可使用等量或等量以上,較佳為大量過剩使 】〇 3]9076 200804429 用,例如為碳酸氫鋼等驗全屬 對於乙醯基化劑丨重量份金==為飽和水溶液,相 本反應可於溶媒中進行,重量:。 (OMSO)、N N- -甲美甲萨a 〇 J牛水、一甲基亞砜 該等可I獨。―種以,^ t」早领及2種以上混合使用,較 ^ 使用量並無特職制,相對 了使用水。洛媒之 份,通常可為丨。至 重量份左右。 伤左右,較佳為1〇〇至1000 反應於-10至10(rc進行, 常於(U i 24小時左右完成。較二Π進行,通 式確認反應的進行。 或負睹法等方 上述乙酿基化反應後之化合物為下式⑺所示者。Nhnh2 (4) [wherein R, R2 and R3 are the same as above]. In the reaction of the present method, the sugar chain aspartate compound represented by the formula (1) has a protecting amine group such as an ethylamine group, and the protecting group is removed from the silk amine group due to excessive tillage. The m-ethyl acylating agent is necessary for N-acetoxylation. The ethylenating agent may be used in the N-acetation reaction, and the acetylating agent may be exemplified by, for example, acetamidine or acetic anhydride such as acetamidine chloride or acetamidine bromide. Preferably, acetic acid liver can be used. The amount of the acetylation agent to be used is m equivalents, preferably about 10 equivalents, per equivalent of the amine group. · The N-acetylation reaction using an acetylation agent can be applied to a conventional method, for example, after distilling off the excess hydrazine under reduced pressure in the reaction solution, in the presence of a base, The action of the agent is completed. For example, a conventional metal pyrite such as sodium carbonate or sodium hydrogen carbonate may be used, and triethylamine or hydrazine may be mentioned. The organic test is determined, and it is particularly preferred to be hydrogen carbonate. Although the amount of the test is not particularly limited, it may be used in an equal amount or more with respect to the ethylating agent, and it is preferably used in a large amount. For example, it is used for hydrogen carbonate steel, for example, for B. The thiolating agent 丨 parts by weight gold == is a saturated aqueous solution, and the phase reaction can be carried out in a solvent, weight:. (OMSO), N N--甲甲甲萨a 〇 J Niu Shui, monomethyl sulfoxide These can be I. ―Types, ^ t" early collar and more than 2 kinds of mixed use, there is no special system compared to ^ usage, relative to the use of water. The share of Luo Media is usually 丨. To about the weight. The damage is about 1 to 1000, preferably from -10 to 10 (rc is carried out, often (U i is completed in about 24 hours. It is carried out in comparison with the second enthalpy, and the general formula confirms the progress of the reaction. The compound after the acetylation reaction is represented by the following formula (7).

NHNHAc [式中,R1至]^4爲.. ^ … 及Ac為與上述者相同]。 如上述方式所製得之 ,生成物,經由勝體過濾管㈣法處鏈化合物 胺殘基等的切斷# p可去除天冬醯 , ;斫片段或經β脫離之糖殘基。 所衣得之式(5)所示肼基糖鏈化叙 製得含有式门、_ 勿、、主由酸處理,可 有式⑴所π糖鏈化合物之生成物。 所使用的酸,可丨與 甲酸、乙酸、… 瓜酸、磷酸等無機酸類, 二弗飞乙峨酸類,酸、乙侧石黃酸 319076 ]3 200804429 ^其中,由安全性或使”便性的觀點而言,較佳為乙 量:相對於式(5)所示肼基糖鏈化合 5二…即可,並無特別限制,較佳為!: 5當里。通常以式(5)所示化 』^為1至 度的方式添加酸為較佳。 7命液王現充分酸性程 行 成 物 較佳以10小時左右完 如以上方式可製造含:42)確/1 應的進行。 上述肼分解中,於不產4 R不糖鏈化合物之生成 原料之式(1)所-輪、生β脫離的階段終止反應時, J八(4)所不肼基糖鏈人 混入。再者,式σ Ν-乙酿基體(6) 亦產生β脱雜。因此糖=不安定’隨時間經過而 物,確越有化合物之式(2)所示糖鍵化合 - ()寺其他化合物的混入。 R3NHNHAc [wherein, R1 to]^4 are: . . . and Ac is the same as the above]. As described in the above manner, the product can be removed by the cutting #p of the chain compound amine residue or the like via the sheng filter tube (four) method, or the ruthenium fragment or the sugar residue decomposed by β. The mercapto sugar chaining represented by the formula (5) is a product of a saccharide chain compound of the formula (1), which is contained in the formula, and is mainly treated with an acid. The acid used can be used with formic acid, acetic acid, ... inorganic acids such as cucurbitic acid, phosphoric acid, etc., difosmetic acid, acid, and ethyl tartaric acid 319076 ] 3 200804429 ^ where, by safety or "convenience" In view of the above, it is preferable that the amount is two: it is not particularly limited with respect to the thiol chain compound represented by the formula (5), and is preferably: ! It is preferred to add an acid in a manner of 1 to 10. The liquid phase of the liquid is preferably about 10 hours, and the above method can be used to produce: 42) sure / 1 should be carried out. In the decomposition of hydrazine, when the reaction is terminated at the stage of the detachment of the formula (1) in which the 4 R non-sugar chain compound is not produced, the J VIII (4) saccharide chain is mixed. , σ Ν 乙 乙 乙 乙 ( ( ( ( ( ( ( ( 乙 。 。 。 。 。 。 。 ( ( ( ( ( ( ( ( ( ( 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 糖 。 。 Mix in. R3

式()所㈣合物訂柄示者。 V^NHNHAc NHAc (6) 匕:,:二至〜c為與上述者相同]。 合…合==式(2)所示糖鍵化合物及其他化 於溶媒中與胺化合物作用。 319076 12 200804429 胺化合物,例如可列舉甲基胺、乙基胺、異丙胺等碳 ^ 之料基胺’環丙基胺、環丁基胺、環戊基胺、 •環己基胺、環庚基胺、環辛美脸笪# * α —女寻厌數3至8之環烷基胺, 二美,可甲基胺類。具有取代基之苯甲基胺類的取 ^ 了列舉氟、氯、漠等齒原子,甲基、乙基、丙基、 兴丙基、弟三丁基等碳數1 工^m H基,甲虱基、乙氧基、 丙乳基、異丙氧基、第三丁氧美 & j羊L丞寺虎乳基,硝某耸· ,該等取代基係單獨或於苯環緣♦,包各 + 丁门t、 仕思位置,為2至5個相同 -或不同之取代者。該等苯甲基胺 一 脸 田# # # 、、中’車父4土可例示苯甲基 月女'對甲乳基苯甲基基胺、2,4,5_三:土 特佳為對甲氧基苯甲基胺。 土 土胺,八中 月女化合物的使用量,相對 量,通常為i至20告量,^1 糖鍵化合物1當 田里較佳為2至1〇當量。 本反應較佳於樟腦磺酸等酸存下進行: 酸的使用量,相對於式⑴所示 0.01至5當量,較佳為0 05 θ 。物1田里為 1虽夏。 本反應中所使用之溶媒, , (DMSO)、Ν,Ν-二甲基甲酿胺(D巧舉水、:甲基亞砜 該等可單獨或2種以上混合使用。、四氫咬喃(THF)等, 溶媒的使用量並無特別限制, 合物1重量份,通常為1〇至2〇〇〇 =於式(2)所示糖鏈化 至1000重量份左右。 重董份左右,較佳為100 本反應通常於0至一 行,通常於1至24小時左右蛀 k彳土於1 0至5(Tc進 ° 。較佳以TLC或質譜法 3]9076 13 200804429 等方式追蹤反應的進行,於 . 舻攄太及雇、原科4失之時點終止反應。 ^ 心、,可衣得於糖鏈還原末 •代之式⑺所示胺基糖鏈化合 而、、Ά基化合物取 定,不產U麟,合物對於驗亦為安 原料中混入式⑹所示之肼基糖鏈化 =反:之 適當之胺基取代化合物。 /、问樣反應,賦予The formula (4) is a handle of the formula. V^NHNHAc NHAc (6) 匕:,: two to ~c are the same as above]. The compound of the glyco bond represented by the formula (2) and the like are reacted with an amine compound in a solvent. 319076 12 200804429 The amine compound may, for example, be a carbon amine such as methylamine, ethylamine or isopropylamine. 'Cyclopropylamine, cyclobutylamine, cyclopentylamine, • cyclohexylamine, cycloheptyl. Amine, ring Xinmei face 笪 # * α - female annoying number 3 to 8 cycloalkylamine, two beautiful, methylamines. The benzylamines having a substituent include a fluorine atom, a chlorine atom, a chlorine atom, a water atom, a methyl group, a methyl group, a propyl group, a propyl group, and a tributyl group. Methyl decyl, ethoxy, propyl acrylate, isopropoxy, succinimide & j sheep L 丞 虎 虎 虎 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , each package + Dingmen t, Shisi location, for 2 to 5 identical - or different replacement. The benzylamine-one-face field ## #,,中中,车家四土 can be exemplified as benzyl methyl moon female 'p-methyl benzyl benzylamine, 2, 4, 5 _ three: terte good P-methoxybenzylamine. The amount of the soil compound, the relative amount, is usually from i to 20, and the compound 1 is preferably 2 to 1 equivalent in the field. The reaction is preferably carried out in the presence of an acid such as camphorsulfonic acid: the amount of the acid used is 0.01 to 5 equivalents, preferably 0 05 θ, relative to the formula (1). 1 in the field is 1 summer. The solvent used in the reaction, (DMSO), hydrazine, hydrazine-dimethyl ketoamine (D water, methyl sulfoxide, etc. may be used alone or in combination of two or more. (THF) or the like, the amount of the solvent to be used is not particularly limited, and the amount of the compound is usually from 1 Torr to 2 Torr = about 5,000 parts by weight in the formula (2). Preferably, the reaction is usually carried out in 0 to one row, usually about 1 to 24 hours, and the 蛀k bauxite is at 10 to 5 (Tc into °. preferably by TLC or mass spectrometry 3) 9076 13 200804429 In the process of . 及 及 及 雇 雇 雇 雇 雇 原 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ It is determined that the U-lin is not produced, and the compound is also mixed with the thiol-chaining compound represented by the formula (6) in the raw material, and the appropriate amine-substituted compound is given.

NHAc NHAc (7) [式中,R1、R2、r3、r4 表示石炭數1至4之C為與上述者相同;R8 基之苯甲基]。 土石厌3至8之環烷基、具有取代 本文中’ R8之碳數1至4 異丙基等;碳數3至8 WA…可列舉节基、乙基、 環戊基、環己基1庚:%= 可列舉環丙基、環丁基、 美之取抑其 讀基、料基等。具有取代基之苯甲 f:取:基,可列舉氟、氯、漠等齒原子,甲基、乙基 土 一丙基、第三丁基等碳數】 土 乙氧基、丙氧基、異丙氧基、第三丁氧氧^ 至等;St代基係— 苯 基苯甲基為特佳。 〜4,5-二甲乳基,其中以對甲氧 管柱式⑺所示胺基糖鏈化合物及其他化合物,以 "處理即可單離精製式⑺所示之胺基糖鏈化合物。 319076 14 200804429 以層析法進行的分離 -或複數個組合佶田二、 Γ將合適、習知的層析法單獨 (用而進杆,/ •後,使用逆相么总4 例如可經膠體過濾層析法精製 逆相層析而精製。 陰離子交換系管桂如0DS、'系、腈系,或 份係與ODS管柱的十所不胺基糖鏈化合物之胺基部 離能力優異。分離條八燒基產生甚強的交互作用,而使分 -以調整。、’可參照合適、習知的條件並加 之:鏈化合物為新賴化合物。 作用,即可成為目的物之+()所不胺基糖鍵化合物,與酸 所使用# 式(2)所示糖鏈化合物。 所使用之酸可列舉鹽酸 酸、乙酸、r g ^ Λ ^ 力L 欠、件酉夂等無機酸類,甲 西4心 寻幾酸類’較佳為_来員,直由 馱為使用上安全且簡便而較佳。怖…其中,乙 酸的使用量,相對於式 量’只要為1當量以上即可:知基糖鏈化合物1當 5當量。通常以式⑺所示化合物二較佳為1至 度的方式添加酸為較佳。 / 合液王現充分酸性程 本反應通常於0至5〇t進行,較佳於1〇 通常於1至15小時左右結束,較佳於^1至⑽進行, 束’且較佳以TIX或質譜等方 G小時左右結 所衣付之式(2)所示糖鏈化合物,^ 【實施方式】 Α層析法等精製。 (實施發明之最佳形態) 319076 15 200804429 以下雖列舉實施例說明,但本發明並不以該等實施例 - 為限。 .實施例1 於糖鏈天冬醯胺化合物(1-1)1 Omg中,加入肼水合物 (肼55%) 10ml,於室温溶解。將其於100°C加熱回流。以 TLC(異丙醇:1M乙酸銨水溶液=1 : 1)追蹤反應,於TLC 上原料消失的時點停止加熱回流。再者,由於糖鏈天冬醯 ,胺化合物(1-1)中,添加肼水合物後,Fmoc基立即脫離,以 -Fmoc基經脫離之糖鏈天冬醯胺化合物作為原料取用。NHAc NHAc (7) [wherein, R1, R2, r3, and r4 represent C of the carbon number of 1 to 4 are the same as those of the above; benzyl group of the R8 group]. The earth-alkaline is a cycloalkyl group of 3 to 8, having a carbon number of 1 to 4 isopropyl, etc., substituted by 'R8 herein; a carbon number of 3 to 8 WA... may be exemplified by a group, an ethyl group, a cyclopentyl group, and a cyclohexyl group. : % = exemplified by cyclopropyl, cyclobutyl, and the like, the base thereof, the base, and the like. Benzene f having a substituent: a group: a fluorine atom such as fluorine, chlorine or molybdenum, a carbon number such as a methyl group, a ethyl chloride-propyl group, a third butyl group, etc., an earth ethoxy group, a propoxy group, Isopropoxy group, third butoxide oxygen to the same; St-based system - phenylbenzyl is particularly preferred. The ~4,5-dimethyl emulsion group in which the amino sugar chain compound represented by the formula (7) and the other compound are treated with " can be used to separate the amino sugar chain compound represented by the formula (7). 319076 14 200804429 Separation by chromatography - or a combination of several combinations of 佶田二, Γ separate and appropriate chromatographic methods (use the rod, / /, after using the reverse phase, total 4, for example, by colloid Purification by reversed-phase chromatography by filtration chromatography. Anion exchange system such as 0DS, 'system, nitrile system, or 10 parts of non-amino sugar chain compound of ODS column has excellent amine base separation ability. The eight-burning base produces a strong interaction, and the fraction-to-adjustment. ' can refer to suitable and well-known conditions and add: the chain compound is a new compound. The effect can be the target +() A non-amino sugar-bonding compound and a sugar chain compound represented by formula (2) are used as an acid. Examples of the acid to be used include hydrochloric acid, acetic acid, rg ^ Λ ^ force L owed, and inorganic acids such as hydrazine. It is better to find a few acids, preferably _ _ _ _ _ _ _ _ _ _ _ _ _ _ ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... Chain compound 1 is 5 equivalents. Usually, compound 2 represented by formula (7) is preferably 1 to It is preferred to add an acid in a manner of a degree. / The liquid phase is sufficiently acidic. The reaction is usually carried out at 0 to 5 Torr, preferably at 1 Torr, usually at about 1 to 15 hours, preferably at from 1 to 10 It is preferable to use a sugar chain compound of the formula (2) which is a T2 or a mass spectrometer, such as a TIX or a mass spectrometer, and the like. (Example) Purification by hydrazine chromatography or the like. (Best form for carrying out the invention) 319076 15 200804429 The following description of the examples is given, but the present invention is not limited to the examples. Example 1 In the sugar chain aspartate compound (1-1) 1 Omg, hydrazine hydrate (肼55%) 10 ml, dissolved at room temperature, and heated to reflux at 100 ° C. The reaction was followed by TLC (isopropanol: 1 M aqueous ammonium acetate = 1 : 1), and the reflux was stopped at the time when the material disappeared on the TLC. In the amine compound (1-1), after the addition of the hydrazine hydrate, the Fmoc group is immediately detached, and the oligosaccharide chain aspartate compound is taken as a raw material by the -Fmoc group.

(1-1) 反應液於減壓下濃縮至乾固,所製得之殘渣中添加水 1 ml使溶解。該水溶液中加入碳酸氫納粉末至飽和後,加 入乙酸酐(0· 1 ml)。反應以TLC(異丙醇·· 1Μ乙酸錢水溶液 = 1.5 : 1)追蹤乙醯基化的進行。以TLC(異丙醇:1Μ乙酸 銨水溶液: 1)確認原料消失後,以使反應液的pH成為7 至8的方式,加入碳酸氫鈉粉末中和之。 反應液於減壓下濃縮至乾固,所得殘渣溶於水1 ml ]6 319076 200804429 中,以膠體過濾層析(管柱載體:Sephadex G-25,管柱尺 寸:0 16mm><345mm,流速:0.8ml/min,展開溶媒:水) •製備含有化合物(5-1)的分液(fraction),於減壓下濃縮。(1-1) The reaction solution was concentrated to dryness under reduced pressure, and 1 ml of water was added to the residue to dissolve. After the sodium hydrogencarbonate powder was added to the aqueous solution to be saturated, acetic anhydride (0.1 ml) was added. The reaction was followed by TLC (isopropanol··1Μ acetic acid aqueous solution = 1.5:1) to follow the progress of acetylation. After confirming the disappearance of the raw material by TLC (isopropyl alcohol: 1 Μ aqueous ammonium acetate solution: 1), the sodium hydrogencarbonate powder was neutralized so that the pH of the reaction liquid became 7 to 8. The reaction mixture was concentrated to dryness under reduced pressure, and the obtained residue was dissolved in water (1 ml) 6 319076 200804429 to colloidal filtration chromatography (column carrier: Sephadex G-25, column size: 0 16 mm><345 mm, Flow rate: 0.8 ml/min, developing solvent: water) • A fraction containing the compound (5-1) was prepared and concentrated under reduced pressure.

將所製得之濃縮殘渣5mg溶於水lml中,加入乙酸 5 72μ1作成乙酸水溶液。於室温攪拌,反應以TLC(異丙醇: 1Μ乙酸銨水溶液= 1.5 : 1)追蹤。6.5小時後,確認反應終 了,以1Μ氮氧化納水溶液中和東結乾餘成為粉體。 所製得之粉體以膠體管柱過濾層析(與上述相同條件) 精製,製備含目的化合物(2-1)之分液(fraction),於減壓下 濃縮,製得化合物(2-1)。惟,確認有源自未反應原料之化 合物(1-2)及經β脫離之化合物(8)混入。 產量:8.9mg[化合物(2-1):化合物(2-2):化合物(8)=90 : 8 : 2] 化合物(2-1) 17 319076 200804429 'H-NMR (4 0 0MHz, 2 9 5 K, HOD = 4.8l) , 5.2 8 (b d, 1H, GlcNAcl —H— 1), 5.23 ( s , 1 Η, M a n 4 一 H — 1), 5.0 3 ( s , 1 H, Man4’一 H-l), 4.8 6 ( s , 1 H, Man3 — H — 1)「4.7 0 (m, 3H, GlcNAc2,5,5’一H — 1), 4.5 3 (d, 2H, G a 1 6, 6’一H—1), 4.34 (b s , 1 H,5 mg of the concentrated residue thus obtained was dissolved in 1 ml of water, and acetic acid 5 72 μl was added to prepare an aqueous acetic acid solution. Stir at room temperature and the reaction was followed by TLC (isopropanol: 1 aqueous ammonium acetate = 1.5:1). After 6.5 hours, it was confirmed that the reaction was completed, and the aqueous solution was neutralized with 1 Torr of nitrogen oxide to form a powder. The obtained powder was purified by a gel column chromatography (same conditions as above) to prepare a fraction containing the objective compound (2-1), and concentrated under reduced pressure to give a compound (2-1). ). However, it was confirmed that the compound (1-2) derived from the unreacted raw material and the compound (8) desorbed by β were mixed. Yield: 8.9 mg [Compound (2-1): Compound (2-2): Compound (8) = 90: 8 : 2] Compound (2-1) 17 319076 200804429 'H-NMR (4 0 0 MHz, 2 9 5 K, HOD = 4.8l), 5.2 8 (bd, 1H, GlcNAcl - H-1), 5.23 ( s , 1 Η, M an 4 - H - 1), 5.0 3 ( s , 1 H, Man4 ' Hl), 4.8 6 ( s , 1 H, Man3 — H — 1) “4.7 0 (m, 3H, GlcNAc2, 5, 5′-H – 1), 4.5 3 (d, 2H, G a 1 6, 6 '一H-1', 4.34 (bs, 1 H,

Man3 —H—2) , 4.2 8 (b d, 1 H,M a n 4 — H — 2 ), 4.20 (bd,lH, Man4,一H — 2), 2.76 (bdd,2H, N e u A c 7, 7’一 H—3eq) , 2.17 ( s , 3 H, Ac) , 2.16 ( s , 6 H, A c X 2) , 2.13 ( s , 6H, A c X 3) , 1.80 (d d, 2H, N e u A c 7 , 7’一H — 3ax). 質量:ESI計算值2222,實測值:1110[(M-2)-2] 化合物(8) 質量:ESI 計算值 2019,實測值·· 1008.3[(M-2)·2]Man3 —H—2) , 4.2 8 (bd, 1 H,M an 4 — H — 2 ), 4.20 (bd, lH, Man4, H-2), 2.76 (bdd, 2H, N eu A c 7, 7'-H-3eq), 2.17 ( s , 3 H, Ac) , 2.16 ( s , 6 H, A c X 2) , 2.13 ( s , 6H, A c X 3) , 1.80 (dd, 2H, N Eu A c 7 , 7'-H — 3ax). Mass: ESI calculated 2222, found: 1110 [(M-2)-2] Compound (8) Mass: ESI Calculated value 2019, measured value ······ (M-2)·2]

(1-2) 18 319076 200804429(1-2) 18 319076 200804429

實施例2 將與實施例1同樣方法所製得之化合物(2-1)、化合物 (1-2)及化合物(8)的混合物45mg,溶解於DMSO 3ml中。 於該溶液中,加入對曱氧基苯甲基胺2ml及樟腦磺酸 5mg,維持於恆溫層約37°C下進行反應。 以質譜(1110/-2峰的消失與1170Λ2峰的生成)追蹤反 應,確認反應終了。反應中加入1 OmM氨水稀釋2倍,以 膠體過濾管柱層析(管柱載體:Sephadex G-25,管柱尺寸: 0 10mm X 900mm,流速:0.8ml/min,展開溶媒:50mM 碳酸銨水溶液或氨水(pH 9至10))精製,製備含有化合物 (7-1)之分液,於減壓下濃縮,製得凍結乾燥之化合物(7-1) 粉末。惟,確認有化合物(1-2)及化合物(9)的混入。Example 2 45 mg of a mixture of the compound (2-1), the compound (1-2) and the compound (8) obtained in the same manner as in Example 1 was dissolved in 3 ml of DMSO. To the solution, 2 ml of p-methoxybenzylamine and 5 mg of camphorsulfonic acid were added, and the reaction was carried out at about 37 ° C in a constant temperature layer. The reaction was followed by mass spectrometry (the disappearance of the 1110/-2 peak and the formation of the 1170Λ2 peak) to confirm the end of the reaction. The reaction was diluted 2 times with 1 OmM aqueous ammonia, and colloidal filtration column chromatography (column carrier: Sephadex G-25, column size: 0 10 mm X 900 mm, flow rate: 0.8 ml/min, developing solvent: 50 mM ammonium carbonate aqueous solution) Or aqueous ammonia (pH 9 to 10)), and the fraction containing the compound (7-1) is prepared and concentrated under reduced pressure to obtain a freeze-dried compound (7-1) powder. However, it was confirmed that the compound (1-2) and the compound (9) were mixed.

19 319076 20080442919 319076 200804429

所製得之粉末20mg溶於10mM碳酸氫銨水溶浪,填 充於以10mM碳酸氫銨水溶液完全置換之ODS管枝(管社 載體:Cosmosil 75C18-〇PN(Nacalai Tesque 公司製造)’ 柱尺寸:0.75 x0.75x10cm)。之後,通入載體5倍量之 碳酸氫銨水溶液,使流出化合物(1_2)。之後,通入載體5 倍量之lOmM碳酸氫銨水溶液:乙腈(=98 : 2),洗淨載體 後’通入10mM碳酸氫銨水溶液:乙腈(=96 : 4),化合物 (9)流出後,製備化合物(7-1)。產量:9mg 化合物(7-1) 'H-NMR (4 0 0MHz, HOD^4.8l) , 6 5.11 (s, 1 Η,20 mg of the obtained powder was dissolved in 10 mM ammonium hydrogencarbonate water, and filled in an ODS tube branch completely replaced with a 10 mM aqueous solution of ammonium hydrogencarbonate (manufacturer carrier: Cosmosil 75C18-〇PN (manufactured by Nacalai Tesque)) Column size: 0.75 X0.75x10cm). Thereafter, a 5-fold amount of an aqueous solution of ammonium hydrogencarbonate was passed through the carrier to cause the compound (1_2) to flow out. Thereafter, a carrier of 5 times the amount of 10 mM aqueous solution of ammonium hydrogencarbonate: acetonitrile (= 98: 2) was introduced, and after washing the carrier, '10 mM aqueous solution of ammonium hydrogencarbonate: acetonitrile (=96:4) was passed, and the compound (9) was discharged. , Compound (7-1) was prepared. Yield: 9 mg of compound (7-1) 'H-NMR (400 MHz, HOD^4.8l), 6 5.11 (s, 1 Η,

Man4^H-l) , 4.93 (s, i H, Man4^H^l)\ 4.75 (s , 1 H, Ma η 3-H- 1) , 4 . 5 9 (m, 3 H, G 1 c N A c 2 , 5,5’-H—l),4.43(d,2H,Gal6,6,-H—l), 4·24 (bs, 1H,Man3—H - 2) , 4.18 (bd,1H, Man4 -H-2) , 4. 10 (bd, 1H,Ma n4,-H 一 2), 2·65 (bdd,2H,NeuAc7,7,一H—3eq), 1.71 (dd, 2H, NeuAc7, 7’一H—3ax) 質量:ESI 計算值 2341.8,實測值:;π69·9[(Μ-2)-2] 化合物(9) 20 319076 200804429 質量:ESI 計算值 2139.8,實測值:1068·4[(Μ-2)·2] , 實施例3 、 於實施例2所製得之化合物(7-1 )3mg中加入水1ml成 為水溶液(pH 10)後,加入乙酸約20 // 1。此時的pH約為4。 以質譜(1170/-2峰的消失與1110Λ2峰的生成)追蹤反 應,確認反應終了。於反應液中加入氫氧化鈉水溶液,調 整為pH 5至6,以膠體過濾管柱層析(管柱載體:Sephadex ,G-25,管柱尺寸·· 0 10mm X 900mm,流速·· 0.8ml/min, 、展開溶媒:水)精製,所製得之分液於減壓下濃縮製得純度 (98%)之化合物(2-l)2.5mg。 所製得化合物(2-1)之NMR及質譜數據與上述實施例 1所製得之物相同。 (產業上可利用性) 根據本發明的方法,於肼分解反應中使用安全的肼水 合物,即可製造於還原末端具有游離羥基之N-結合型糖鏈 化合物。 319076Man4^Hl) , 4.93 (s, i H, Man4^H^l)\ 4.75 (s , 1 H, Ma η 3-H- 1) , 4 . 5 9 (m, 3 H, G 1 c NA c 2, 5,5'-H-l), 4.43(d,2H,Gal6,6,-H-l), 4·24 (bs, 1H,Man3—H - 2) , 4.18 (bd,1H, Man4 -H-2) , 4. 10 (bd, 1H, Ma n4, -H-2), 2·65 (bdd, 2H, NeuAc7, 7, H-3eq), 1.71 (dd, 2H, NeuAc7, 7 'H-3ax' mass: ESI calculated 2341.8, found: π69·9[(Μ-2)-2] Compound (9) 20 319076 200804429 Mass: ESI Calculated value 2139.8, found: 1068·4 [ (Μ-2)·2], Example 3, 3 ml of water (pH 10) was added to 3 mg of the compound (7-1) obtained in Example 2, and then acetic acid was added to about 20 //1 . The pH at this time is about 4. The reaction was followed by mass spectrometry (the disappearance of the 1170/-2 peak and the formation of the 1110Λ2 peak), and it was confirmed that the reaction was completed. Add sodium hydroxide aqueous solution to the reaction solution, adjust to pH 5 to 6, and colloidal filtration column chromatography (column carrier: Sephadex, G-25, column size · 0 10mm X 900mm, flow rate · · 0.8ml /min, development solvent: water), and the obtained fraction was concentrated under reduced pressure to obtain a purity (98%) of compound (2-l) 2.5 mg. The NMR and mass spectral data of the obtained compound (2-1) were the same as those obtained in the above Example 1. (Industrial Applicability) According to the method of the present invention, an N-binding type sugar chain compound having a free hydroxyl group at a reducing end can be produced by using a safe hydrazine hydrate in a hydrazine decomposition reaction. 319076

Claims (1)

200804429 、申請專利範圍: 種式(2)所不之糖鏈化合物之製造方法,其特徵係使式 (1)所示之糖鏈天冬醯胺化合物與肼水合物作用··200804429, Patent application range: A method for producing a sugar chain compound of the formula (2), which is characterized in that a sugar chain aspartame compound represented by the formula (1) is reacted with a hydrazine hydrate. 、R5 Γ ψ 5 T? ^ 2 jj η 及R為相同或不同,表示氳原子或糖殘 基’ R表不氫原子或岩藻糖殘基;Ac表示乙醯基;R5 表6不虱原子、脂溶性保護基、胺基酸殘基或胜肽殘基; V表示羧基或; R7表示胺基酸殘基或胜肽殘基] R4 (2) NHAc NHAc [式中,R1、P2 ^, , 、R及R及Ac為與上述者相同1。 如申請專利範圊室 ,m. 乾圍昂1項之製造方法,其中,肼水合物之 作用係於糖4@ I 前終止。鏈避原末端之乙醯基葡糖胺進行沒-脫離 3.下:);:各:一 (Α)使式(1、所- 用的步驟之糖鏈天冬醯胺化合物與肼水合物作 (Β)乙醯化劑作用的步驟, (C)酸作用之步驟, ⑴)與選自碳數 至4之單烷基胺、碳數3至8之環烷 319076 22 200804429 基胺及具有取代基之苯曱基胺之至少一 作用之步驟, 種胺化合物 (E) 以管柱層析精製之步驟,及 (F) 酸作用之步驟。 •申明專利乾圍第3項之製造方法,苴中 合物之作用俜;^+ ,、 (A)之肼水m 原末端之队乙酿基葡糖胺進行 P _脫離珂終止。 J 5·如申請專利範圍第3項之製造方法,其中 合物為對甲氧基苯曱基胺。 6·如申請專利範圍第3項之製造方法,其中 酸為乙酸。 〃 (D)之胺化 (C)及(F)之 種式(7)所示之胺基糖鏈化合物,, R5 Γ ψ 5 T? ^ 2 jj η and R are the same or different, indicating that the ruthenium atom or saccharide residue 'R is not a hydrogen atom or a fucose residue; Ac represents an acetamidine group; R5 is not a ruthenium atom , a fat-soluble protecting group, an amino acid residue or a peptide residue; V represents a carboxyl group; R7 represents an amino acid residue or a peptide residue] R4 (2) NHAc NHAc [wherein R1, P2 ^, , R, R and Ac are the same as the above one. For example, the patent application method, m. Drying ang 1 manufacturing method, wherein the action of hydrazine hydrate is terminated before sugar 4@ I. Ethyl glucosamine at the end of the chain to avoid the detachment 3. Under:);: Each: one (Α) to make the sugar chain aspartate compound and hydrazine hydrate of the formula (1, - a step of acting as a hydrazine, (C) a step of acid action, (1)) and a cycloalkyl group selected from the group consisting of a monoalkylamine having a carbon number of 4 and a cyclohexane having a carbon number of 3 to 319076 22 200804429 and having a step of at least one of the action of the substituent phenylhydrazineamine, a step of purifying the amine compound (E) by column chromatography, and (F) a step of acid action. • Affirmation of the manufacturing method of the third paragraph of the patented circumcision, the role of the 苴 苴 俜; ^ + , , (A) 肼 m m m m m 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 J. The manufacturing method of claim 3, wherein the compound is p-methoxybenzoin. 6. The method of manufacture of claim 3, wherein the acid is acetic acid.胺 (A) Amination (C) and (F) of the amino sugar chain compound of the formula (7), ⑺ [式中,R]、 嚷數I至4 之笨曱基]。 R2、R3及R4及Ac為與 之烷基、碳數3至8之環 上述者相同;R8為 烧基或具有取代基 3]9076 200804429 七、指定代表圖:本案無圖式 , (一)本案指定代表圖為:第()圖。 (二)本代表圖之元件符號簡單說明: 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:(7) [wherein, R], the number of turns I to 4]. R2, R3 and R4 and Ac are the same as those of the alkyl group and the carbon number of 3 to 8; R8 is a burnt group or has a substituent. 3] 9076 200804429 VII. Designated representative figure: No case in the present case, (1) The representative representative figure of this case is: the () picture. (2) A brief description of the symbol of the representative figure: 8. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: 4 3190764 319076
TW096110943A 2006-03-30 2007-03-29 Process for the preparation of sugar-chain compound TW200804429A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006092702A JP2009155353A (en) 2006-03-30 2006-03-30 Method for producing sugar chain compound

Publications (1)

Publication Number Publication Date
TW200804429A true TW200804429A (en) 2008-01-16

Family

ID=38563742

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096110943A TW200804429A (en) 2006-03-30 2007-03-29 Process for the preparation of sugar-chain compound

Country Status (3)

Country Link
JP (1) JP2009155353A (en)
TW (1) TW200804429A (en)
WO (1) WO2007114482A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010163485A (en) * 2009-01-13 2010-07-29 Teijin Ltd Solution of carboxy-polysaccharide
CN116917341A (en) * 2021-03-12 2023-10-20 第一三共株式会社 Sugar chain and method for producing pharmaceutical product containing sugar chain
WO2024053574A1 (en) * 2022-09-09 2024-03-14 第一三共株式会社 Novel oligosaccharide, production intermediate for novel oligosaccharide, production method for novel oligosaccharide, and production method for production intermediate for novel oligosaccharide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1405858T3 (en) * 2001-06-19 2013-02-18 Glytech Inc Process for making sugar chain asparagine derivative.
JP4271924B2 (en) * 2002-10-10 2009-06-03 日本曹達株式会社 Method for producing 4-mercaptophenols
AU2003302165A1 (en) * 2002-12-03 2004-07-29 Sloan-Kettering Institute For Cancer Research Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
TWI335920B (en) * 2002-12-24 2011-01-11 Yasuhiro Kajihara Sugar chain asparagine derivatives, sugar chain asparagine and sugar chain and manufacture thereof

Also Published As

Publication number Publication date
JP2009155353A (en) 2009-07-16
WO2007114482A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
JP4323139B2 (en) Process for producing sugar chain asparagine derivatives
TW379226B (en) Process for preparing 1-(2-deoxy-2'-2'-defluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one) hydrochloride
JPWO2008012949A1 (en) Process for producing di (pyrimidine nucleoside 5'-) polyphosphate
CN107602661B (en) Preparation method of polaprezinc
KR20050085242A (en) Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain, and processes for producing these
TW200804429A (en) Process for the preparation of sugar-chain compound
CN109096346A (en) The method for preparing dinucleotide polyphosphates compound
TW200413408A (en) Saccharide chain asparagine derivatives and manufacture thereof
KR20020013471A (en) Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
AU780604B2 (en) Process for producing an amide compound
JPH11255807A (en) Active ester derivative of sugar-chained asparagine and synthetic intermediate
CN107586267A (en) A kind of synthetic method of tauryl amine hydrochlorate (2 aminoethyl sulfanylamide hydrochloride)
Ross et al. Stereoselective syntheses of α-amino acid and peptide derivatives by the U-4CR of 5-desoxy-5-thio-D-xylopyranosylamine
JPH0959292A (en) Production of 4-aminopyrimidine nucleoside
JP7405991B2 (en) Method for producing uridine 5'-diphosphate (UDP), its salt or its hydrate
US9879097B2 (en) Method for producing activated sugar chain derivative and activated sugar chain derivative produced therefrom
TWI324607B (en)
JPH07242685A (en) Production of diadenosine tetraphosphate hydrate
JP2002187948A (en) Production method for amide compound
JP2949509B2 (en) Sialyl lactose
AU2006203198B2 (en) Sugar chain asparagine derivative
TAKEI et al. Studies on Nucleic Acid Antagonists. XII. Synthesis of Aminosugar Nucleotides
JP2001002648A (en) N-substituted azepan derivative and salt thereof
JPH0984596A (en) Production of galactopyranosylmoranolines
JP2005306782A (en) New method for synthesizing l-carnosine